2-[4,
6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-
hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

Produktsname:	2-[4, 6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2- hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
CAS Registry Number:	1403-66-3
EINECS:	215-765-8
Synonyme:	Uromycine; Cidomycin;Garamycin; Gentamicins;2-[4, 6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2- hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; GENTAMYCIN; gentamicin; Refobacin; Gentamycinum; Gentacycol; Gentavet;
Molecular Structure:
Molecular Formula:	C₂₁H₄₃N₅O₇
Molecular Weight:	477.59542
Dichte:	1.3 g/cm³
Boiling Point:	669.4 °C at 760 mmHg
Flash Point:	358.6 °C
S-Sätze:	Poison by intravenous, intraperitoneal, intramuscular, and subcutaneous routes. Mildly toxic by ingestion. Experimental teratogenic and reproductive effects. Mutation data reported. Human systemic effects: change in motor activity, changes in vestibular functions, distorted perceptions, eye hemorrhage, hallucinations, kidney changes, motor activity changes, trigeminal nerve sensory changes, vestibular function changes, visual field changes. Affects the peripheral nervous system by intravenous route. An antibiotic. When heated to decomposition it emits acrid smoke and irritating fumes. See also GENTAMYCIN SULFATE.

2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol